Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Audiovox Purchases Moore Microprocessor Patent™ Portfolio License

We continue to see strong interest from companies that wish to reduce their royalty exposure and the possibility of supply chain disruptions..

What we're seeing is that lump sum payments are ...STILL...being used as the main source of licenses...those signing up now are probably doing so to save themselves money for sure and in turn lessening our possible revenues esp. on an ongoing basis.

Would you mind the modest and upright request, how do you get to your above convinced conclusion?

Thank you for clearing me up.

All the best

Jerry


Share
New Message
Please login to post a reply